Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 10 de 10
Filter
Add more filters










Publication year range
1.
Article in English | MEDLINE | ID: mdl-30687702

ABSTRACT

L-Asparaginase (ASNase) is a vital component of the first line treatment of acute lymphoblastic leukemia (ALL), an aggressive type of blood cancer expected to afflict over 53,000 people worldwide by 2020. More recently, ASNase has also been shown to have potential for preventing metastasis from solid tumors. The ASNase treatment is, however, characterized by a plethora of potential side effects, ranging from immune reactions to severe toxicity. Consequently, in accordance with Quality-by-Design (QbD) principles, ingenious new products tailored to minimize adverse reactions while increasing patient survival have been devised. In the following pages, the reader is invited for a brief discussion on the most recent developments in this field. Firstly, the review presents an outline of the recent improvements on the manufacturing and formulation processes, which can severely influence important aspects of the product quality profile, such as contamination, aggregation and enzymatic activity. Following, the most recent advances in protein engineering applied to the development of biobetter ASNases (i.e., with reduced glutaminase activity, proteolysis resistant and less immunogenic) using techniques such as site-directed mutagenesis, molecular dynamics, PEGylation, PASylation and bioconjugation are discussed. Afterwards, the attention is shifted toward nanomedicine including technologies such as encapsulation and immobilization, which aim at improving ASNase pharmacokinetics. Besides discussing the results of the most innovative and representative academic research, the review provides an overview of the products already available on the market or in the latest stages of development. With this, the review is intended to provide a solid background for the current product development and underpin the discussions on the target quality profile of future ASNase-based pharmaceuticals.

2.
Food Chem Toxicol ; 109(Pt 2): 1103-1110, 2017 Nov.
Article in English | MEDLINE | ID: mdl-28359876

ABSTRACT

An acidic thermostable protease was extracellularly produced either in shake flask or in stirred tank bioreactor by an Aspergillus foetidus strain isolated from the Brazilian savanna soil using different nitrogen sources. Its maximum activity (63.7 U mL-1) was obtained in a medium containing 2% (w/v) peptone. A cultivation carried out in a 5.0 L stirred-tank bioreactor provided a maximum protease activity 9% lower than that observed in Erlenmeyer flasks, which was obtained after a significantly shorter (by 16-29%) time. Protease purification by a combination of gel-filtration chromatography resulted in a 16.9-fold increase in specific activity (248.1 U g-1). The estimated molecular weight of the purified enzyme was 50.6 kDa, and the optimal pH and temperature were 5.0 and 55 °C, respectively. The enzyme was completely inhibited by pepstatin A, and its activity enhanced by some metals. According to the inhibition profiles, it was confirmed that the purified acid protease belongs to the aspartic protease type. These results are quite promising for future development of large-scale production of such protease, which can be useful in biotechnological applications requiring high enzyme activity and stability under acidic conditions.


Subject(s)
Aspartic Acid Proteases/chemistry , Aspartic Acid Proteases/isolation & purification , Aspergillus/enzymology , Fungal Proteins/chemistry , Fungal Proteins/isolation & purification , Aspartic Acid Proteases/genetics , Aspartic Acid Proteases/metabolism , Aspergillus/chemistry , Aspergillus/genetics , Aspergillus/isolation & purification , Brazil , Enzyme Stability , Fungal Proteins/genetics , Fungal Proteins/metabolism , Hydrogen-Ion Concentration , Molecular Weight , Soil Microbiology , Substrate Specificity , Temperature
3.
Braz J Microbiol ; 48(3): 419-426, 2017.
Article in English | MEDLINE | ID: mdl-28237678

ABSTRACT

Antibodies and antibody fragments are nowadays among the most important biotechnological products, and Pichia pastoris is one of the most important vectors to produce them as well as other recombinant proteins. The conditions to effectively cultivate a P. pastoris strain previously genetically modified to produce the single-chain variable fragment anti low density lipoprotein (-) under the control of the alcohol oxidase promoter have been investigated in this study. In particular, it was evaluated if, and eventually how, the carbon source (glucose or glycerol) used in the preculture preceding cryopreservation in 20% glycerol influences both cell and antibody fragment productions either in flasks or in bioreactor. Although in flasks the volumetric productivity of the antibody fragment secreted by cells precultured, cryopreserved and reactivated in glycerol was 42.9% higher compared with cells precultured in glucose, the use of glycerol in bioreactor led to a remarkable shortening of the lag phase, thereby increasing it by no less than thrice compared to flasks. These results are quite promising in comparison with those reported in the literature for possible future industrial applications of this cultivation, taking into account that the overall process time was reduced by around 8h.


Subject(s)
Antibodies/metabolism , Carbon/metabolism , Industrial Microbiology/methods , Pichia/metabolism , Single-Chain Antibodies/biosynthesis , Antibodies/genetics , Culture Media/chemistry , Culture Media/metabolism , Fermentation , Glycerol/metabolism , Lipoproteins, LDL/immunology , Pichia/genetics , Pichia/growth & development , Recombinant Proteins/genetics , Recombinant Proteins/metabolism , Single-Chain Antibodies/genetics
4.
Int J Biol Macromol ; 81: 17-21, 2015 Nov.
Article in English | MEDLINE | ID: mdl-26210038

ABSTRACT

The kinetics of a thermostable extracellular acid protease produced by an Aspergillus foetidus strain was investigated at different pH, temperatures and substrate concentrations. The enzyme exhibited maximal activity at pH 5.0 and 55°C, and its irreversible deactivation was well described by first-order kinetics. When temperature was raised from 55 to 70°C, the deactivation rate constant increased from 0.018 to 5.06h(-1), while the half-life decreased from 37.6 to 0.13h. The results of activity collected at different temperatures were then used to estimate, the activation energy of the hydrolysis reaction (E*=19.03kJ/mol) and the standard enthalpy variation of reversible enzyme unfolding (ΔH°U=19.03kJ/mol). The results of residual activity tests carried out in the temperature range 55-70°C allowed estimating the activation energy (E(*)d=314.12kJ/mol), enthalpy (311.27≤(ΔH°d≤311.39kJ/mol), entropy (599.59≤ΔS(*)d≤610.49kJ/mol K) and Gibbs free energy (103.18≤ΔG(*)d≤113.87kJ/mol) of the enzyme irreversible denaturation. These thermodynamic parameters suggest that this new protease is highly thermostable and could be important for industrial applications. To the best of our knowledge, this is the first report on thermodynamic parameters of an acid protease produced by A. foetidus.


Subject(s)
Aspergillus/enzymology , Peptide Hydrolases/chemistry , Thermodynamics , Caseins/chemistry , Enzyme Activation , Enzyme Stability , Hydrogen-Ion Concentration , Hydrolysis , Kinetics , Substrate Specificity , Temperature
5.
Braz. j. pharm. sci ; 50(2): 371-380, Apr-Jun/2014. tab, graf
Article in English | LILACS | ID: lil-722178

ABSTRACT

Enzyme stability is critical in biotechnology, pharmaceutical and cosmetic industries. Investigations on this subject have drawn attention because of its practical application. Bromelain is a thiol-endopeptidase, obtained from pineapple (Ananas comosus), known for its clinical and therapeutic applications, particularly to selective burn debridement and improvement of antibiotic action and anti-inflammatory activities. To date, the use of bromelain in pharmacological or industrial applications is limited, due to commercial availability, costs, and sensitivity to pH and temperature. Therefore, a better understanding of enzyme stability would be of great interest. The aim of this study was to evaluate bromelain activity and stability in several pH (2.0 to 8.0) and in polyethylene glycol and polyacrylic acid solutions. We observed that bromelain was able to maintain its stability at pH 5.0 for the temperatures studied. PEG solutions increased bromelain stability, but PAA solutions had the opposite effect.


Estabilidade de enzimas é uma questão fundamental em indústrias biotecnológicas, farmacêuticas e cosméticas. As investigações sobre o assunto têm chamado a atenção por sua aplicação prática. A bromelina é uma tiol-endopeptidase, obtida a partir do abacaxi (Ananas comosus). É conhecida por suas aplicações clínicas e terapêuticas, especialmente para desbridamento seletivo de queimaduras, melhoria de ações antibiótica e de atividades anti-inflamatórias. Até o momento, a utilização da bromelina em aplicações farmacológicas industriais é limitada, devido à disponibilidade comercial, os custos, a sensibilidade ao pH e temperatura. Portanto, a maior compreensão da estabilidade desta enzima seria de grande interesse. O objetivo deste estudo foi avaliar a estabilidade da atividade da bromelina em vários pH (2,0 a 8,0) e em soluções de polietilenoglicol e de ácido poliacrílico. Observamos que a bromelina foi capaz de manter a sua estabilidade em pH 5.0, em todas as temperaturas estudadas. Soluções de PEG aumentaram a estabilidade da bromelina, enquanto que soluções de PAA obtiveram efeito oposto.


Subject(s)
Bromelains/analysis , Alkalinization/adverse effects , Polyethylene Glycols/analysis , Enzyme Stability , Enzymes
6.
Biotechnol Prog ; 29(6): 1343-53, 2013.
Article in English | MEDLINE | ID: mdl-23925947

ABSTRACT

Upstream improvements have led to significant advances in the productivity of biomolecules and bioparticles. Today, downstream processes are the bottleneck in the production of some biopharmaceuticals, a change from previous years. Current purification platforms will reach their physical limits at some point, indicating the need for new approaches. This article reviews an alternative method to extract and purify biomolecules/bioparticles named aqueous two-phase system (ATPS). Biocompatibility and readiness to scale up are some of the ATPS characteristics. We also discuss some of ATPS applications in the biotechnology field.


Subject(s)
Biotechnology , Proteins/isolation & purification , Water/chemistry , Biopharmaceutics , Humans , Proteins/chemistry
7.
Biol Trace Elem Res ; 145(1): 71-80, 2012 Jan.
Article in English | MEDLINE | ID: mdl-21809054

ABSTRACT

Most of the metals released from industrial activity, among them are cadmium (Cd) and nickel (Ni), inhibit the productivity of cultures and affect microbial metabolism. In this context, the aim of this work was to investigate the capacity of sugar cane vinasse to mitigate the adverse effects of Cd and Ni on cell growth, viability, budding rate and trehalose content of Saccharomyces cerevisiae, likely because of adsorption and chelating action. For this purpose, the yeast was grown batch-wise in YED medium supplemented with selected amounts of vinasse and Cd or Ni. The negative effects of Cd and Ni on S. cerevisiae growth and the mitigating one of sugar cane vinasse were quantified by an exponential model. Without vinasse, the addition of increasing levels of Cd and Ni reduced the specific growth rate, whereas in its presence no reduction was observed. Consistently with the well-proved toxicity of both metals, cell viability and budding rate progressively decreased with increasing their concentration, but in the presence of vinasse the situation was remarkably improved. The trehalose content of S. cerevisiae cells followed the same qualitative behavior as cell viability, even though the negative effect of both metals on this parameter was stronger. These results demonstrate the ability of sugar cane vinasse to mitigate the toxic effects of Cd and Ni.


Subject(s)
Cadmium/toxicity , Nickel/toxicity , Plant Preparations/pharmacology , Saccharomyces cerevisiae/drug effects , Saccharum/chemistry , Dose-Response Relationship, Drug , Fermentation , Kinetics , Molasses , Saccharomyces cerevisiae/growth & development , Saccharomyces cerevisiae/metabolism , Time Factors , Trehalose/metabolism
8.
Appl Biochem Biotechnol ; 113-116: 453-68, 2004.
Article in English | MEDLINE | ID: mdl-15054270

ABSTRACT

To determine the influence of various culture conditions, transformed cells of Escherichia coli expressing recombinant green fluorescent protein (GFPuv) were grown in nine cultures with four variable conditions (storage of inoculated broth at 4 degrees C prior to incubation, agitation speed, isopropyl-beta-D-thiogalactopyranoside [IPTG] concentration, and induction time). The pelleted cells were resuspended in extraction buffer and subjected to the three-phase partitioning (TPP) extraction method. To determine the most appropriate purification resin, protein extracts were eluted through one of four types of HiTrap hydrophobic interaction chromatography (HIC) columns prepacked with methyl, butyl, octyl, or phenyl resins and analyzed further on a 12% sodium dodecylsulfate polyacrylamide gel. With Coomassie staining, a single band between 27 (standard GFPuv) and 29 kDa (molecular weight standard) was visualized for every HIC column sample. TPP extraction with HIC elution provided about 90% of the GFPuv recovered and eight-fold GFPuv enrichment related to the specific mass. Rotary speed and IPTG concentration showed, respectively, greater negative and positive influences on GFPuv expression at the beginning of the logarithmic phase for the set culture conditions (37 degrees C, 24-h incubation).


Subject(s)
Biotechnology/methods , Chromatography/methods , Luminescent Proteins/chemistry , Proteins/isolation & purification , Recombinant Proteins/chemistry , Animals , Chromatography, Affinity/methods , Electrophoresis, Polyacrylamide Gel , Escherichia coli/metabolism , Green Fluorescent Proteins , Hydrogen-Ion Concentration , Isopropyl Thiogalactoside/chemistry , Luminescent Proteins/metabolism , Plasmids/metabolism , Proteins/chemistry , Temperature , Time Factors
9.
Appl Biochem Biotechnol ; 113-116: 469-83, 2004.
Article in English | MEDLINE | ID: mdl-15054271

ABSTRACT

The thermal stability of the recombinant green fluorescent protein (GFPuv) expressed by Escherichia coli cells and isolated by three-phase partitioning extraction with hydrophobic interaction chromatography was studied. The GFPuv (3.5-9.0 microg of GFPuv/mL) was exposed to various pH conditions (4.91-9.03) and temperatures (75-95 degrees C) in the 10 mM buffers: acetate (pH 5.0-7.0), phosphate (pH 5.5-8.0), and Tris-HCl (pH 7.0-9.0). The extent of protein denaturation (loss of fluorescence intensity) was expressed in decimal reduction time (D-value), the time exposure required to reduce 90% of the initial fluorescence intensity of GFPuv. For pH 7.0 to 8.0, the thermostability of GFPuv was slightly greater in phosphate buffer than in Tris-HCl. At 85 degrees C, the D-values (pH 7.1-7.5) ranged from 7.24 (Tris-HCl) to 13.88 min (phosphate). The stability of GFPuv in Tris-HCl (pH >8.0) was constant at 90 and 95 degrees C, and the D-values were 7.93 (pH 8.38-8.92) and 6.0 min (pH 8.05-8.97), respectively. The thermostability of GFPuv provides the basis for its potential utility as a fluorescent biologic indicator to assay the efficacy of moist-heat treatments at temperatures lower than 100 degrees C.


Subject(s)
Biotechnology/methods , Luminescent Proteins/chemistry , Acetates/chemistry , Buffers , Chromatography , Escherichia coli/metabolism , Green Fluorescent Proteins , Hot Temperature , Hydrogen-Ion Concentration , Kinetics , Luminescent Proteins/metabolism , Phosphates/chemistry , Recombinant Proteins/chemistry , Spectrometry, Fluorescence , Temperature , Time Factors
10.
Appl Biochem Biotechnol ; 105 -108: 481-91, 2003.
Article in English | MEDLINE | ID: mdl-12721429

ABSTRACT

Transformed cells of Escherichia coli expressing recombinant green fluorescent protein (GFPuv) were subjected to two methods of extraction: (1) freezing/thawing/sonication (FTS) cycles prior to the three-phase partitioning (TPP) method, or (2) directly to TPP extraction. The amount of GFPuv released by the FTS plus TPP method varied: 374 microg/mL (first cycle), 93-442 microg/mL (second cycle), 32-359 microg/mL (third cycle), 18-115 microg/mL (fourth cycle). The GFPuv yields by the second method (TPP only) were, 23-54 microg/mL for the first extract and 33-91 microg/mL for the second. The FTS plus TPP method released similar amounts of GFPuv to that extracted by TPP; and provided a better mixture elution through the hydrophobic interaction column: 13-63 microg/mL for FTS plus TPP methods, and 2.5-13 microg/mL for TPP. The results showed that although selective permeation is a more laborious methodology, it was more efficient for obtaining of GFPuv in relation to the direct extraction of the cells for TPP.


Subject(s)
Escherichia coli/genetics , Luminescent Proteins/metabolism , Cloning, Molecular , Electrophoresis, Polyacrylamide Gel/methods , Escherichia coli/physiology , Fermentation , Genes, Reporter , Green Fluorescent Proteins , Kinetics , Luminescent Proteins/genetics , Luminescent Proteins/isolation & purification , Recombinant Proteins/isolation & purification , Recombinant Proteins/metabolism , Spectrometry, Fluorescence/methods , Transformation, Bacterial
SELECTION OF CITATIONS
SEARCH DETAIL
...